Lidia Gaffke

4.3k total citations · 1 hit paper
78 papers, 1.3k citations indexed

About

Lidia Gaffke is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lidia Gaffke has authored 78 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Physiology, 24 papers in Molecular Biology and 24 papers in Epidemiology. Recurrent topics in Lidia Gaffke's work include Lysosomal Storage Disorders Research (37 papers), Trypanosoma species research and implications (16 papers) and Cellular transport and secretion (13 papers). Lidia Gaffke is often cited by papers focused on Lysosomal Storage Disorders Research (37 papers), Trypanosoma species research and implications (16 papers) and Cellular transport and secretion (13 papers). Lidia Gaffke collaborates with scholars based in Poland, United Kingdom and Russia. Lidia Gaffke's co-authors include Grzegorz Węgrzyn, Karolina Pierzynowska, Zuzanna Cyske, Magdalena Podlacha, Estera Rintz, Weronika Jaroszewicz, Jagoda Mantej, Ewa Piotrowska, Alicja Węgrzyn and Łukasz Grabowski and has published in prestigious journals such as Nature Communications, PLoS ONE and Water Research.

In The Last Decade

Lidia Gaffke

74 papers receiving 1.2k citations

Hit Papers

Phage display and other peptide display technologies 2021 2026 2022 2024 2021 50 100 150

Peers

Lidia Gaffke
Lidia Gaffke
Citations per year, relative to Lidia Gaffke Lidia Gaffke (= 1×) peers Karolina Pierzynowska

Countries citing papers authored by Lidia Gaffke

Since Specialization
Citations

This map shows the geographic impact of Lidia Gaffke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Gaffke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Gaffke more than expected).

Fields of papers citing papers by Lidia Gaffke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidia Gaffke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Gaffke. The network helps show where Lidia Gaffke may publish in the future.

Co-authorship network of co-authors of Lidia Gaffke

This figure shows the co-authorship network connecting the top 25 collaborators of Lidia Gaffke. A scholar is included among the top collaborators of Lidia Gaffke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lidia Gaffke. Lidia Gaffke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cyske, Zuzanna, Estera Rintz, Magdalena Narajczyk, et al.. (2025). Cellular and molecular changes in mucopolysaccharidosis-plus syndrome caused by a homozygous c.599G > C (p.Arg200Pro) variant of the VPS33A gene. Journal of Applied Genetics. 1 indexed citations
2.
Cyske, Zuzanna, et al.. (2024). Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease. Neurochemistry International. 178. 105774–105774. 8 indexed citations
3.
Grabowski, Łukasz, Estera Rintz, Zuzanna Cyske, et al.. (2024). Cyanobacteria and their metabolites - can they be helpful in the fight against pathogenic microbes?. 1(1). 3 indexed citations
4.
Rintz, Estera, et al.. (2024). Synergistic effects of resveratrol and enzyme replacement therapy in the Mucopolysaccharidosis type I. Biochemical Pharmacology. 229. 116467–116467. 1 indexed citations
5.
Podlacha, Magdalena, Lidia Gaffke, Łukasz Grabowski, et al.. (2024). Bacteriophage DNA induces an interrupted immune response during phage therapy in a chicken model. Nature Communications. 15(1). 2274–2274. 21 indexed citations
6.
Gaffke, Lidia, et al.. (2024). Cellular Organelle-Related Transcriptomic Profile Abnormalities in Neuronopathic Types of Mucopolysaccharidosis: A Comparison with Other Neurodegenerative Diseases. Current Issues in Molecular Biology. 46(3). 2678–2700. 1 indexed citations
7.
Rintz, Estera, Lidia Gaffke, Magdalena Podlacha, et al.. (2024). Comprehensive evaluation of pathogenic protein accumulation in fibroblasts from all subtypes of Sanfilippo disease patients. Biochemical and Biophysical Research Communications. 733. 150718–150718. 1 indexed citations
8.
Gaffke, Lidia, et al.. (2024). Mucopolysaccharidosis Type IIIE: A Real Human Disease or a Diagnostic Pitfall?. Diagnostics. 14(16). 1734–1734. 4 indexed citations
9.
Pierzynowska, Karolina, Lidia Gaffke, Jan Maciej Zaucha, & Grzegorz Węgrzyn. (2023). Transcriptomic Approaches in Studies on and Applications of Chimeric Antigen Receptor T Cells. Biomedicines. 11(4). 1107–1107.
10.
Pierzynowska, Karolina, Magdalena Podlacha, Lidia Gaffke, et al.. (2023). Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation. Autophagy. 20(5). 1159–1182. 14 indexed citations
11.
Gaffke, Lidia, Magdalena Podlacha, Estera Rintz, et al.. (2023). Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach. Pharmaceutics. 15(2). 704–704. 5 indexed citations
12.
Kujawa, M., Jolanta Wierzba, Karolina Pierzynowska, et al.. (2023). Clinical presentation of 13 children with alkaptonuria. Journal of Inherited Metabolic Disease. 46(5). 916–930. 1 indexed citations
13.
Pierzynowska, Karolina, Lidia Gaffke, Zuzanna Cyske, et al.. (2023). Roles of the Oxytocin Receptor (OXTR) in Human Diseases. International Journal of Molecular Sciences. 24(4). 3887–3887. 29 indexed citations
14.
Gaffke, Lidia, Estera Rintz, Karolina Pierzynowska, & Grzegorz Węgrzyn. (2023). Actin Cytoskeleton Polymerization and Focal Adhesion as Important Factors in the Pathomechanism and Potential Targets of Mucopolysaccharidosis Treatment. Cells. 12(13). 1782–1782. 2 indexed citations
15.
Gaffke, Lidia, et al.. (2023). Enhanced Efficiency of the Basal and Induced Apoptosis Process in Mucopolysaccharidosis IVA and IVB Human Fibroblasts. International Journal of Molecular Sciences. 24(18). 14119–14119. 4 indexed citations
16.
Wierzba, Jolanta, Aleksander Jamsheer, Zuzanna Cyske, et al.. (2022). Highly diverse phenotypes of mucopolysaccharidosis type IIIB sibling patients: effects of an additional mutation in the AUTS2 gene. Journal of Applied Genetics. 63(3). 535–542. 2 indexed citations
17.
Grabowski, Łukasz, et al.. (2022). The use of phage display systems to combat infectious diseases in poultry: diagnostic, vaccine, and therapeutic approaches. Journal of Applied Microbiology. 134(1). 4 indexed citations
18.
Gaffke, Lidia, Karolina Pierzynowska, Zuzanna Cyske, et al.. (2022). Determination of Effects and Mechanisms of Action of Bacterial Amyloids on Antibiotic Resistance. Methods in molecular biology. 2538. 189–205. 2 indexed citations
19.
Pierzynowska, Karolina, et al.. (2020). Untypically mild phenotype of a patient suffering from Sanfilippo syndrome B with the c.638C>T/c.889C>T (p.Pro213Leu/p.Arg297Ter) mutations in the NAGLU gene. Molecular Genetics & Genomic Medicine. 8(9). e1356–e1356. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026